← Back to Search

Screening Tools for Colorectal Cancer

N/A

Waitlist Available

Led By Celette Skinner, PhD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male or female patients, ages 25-64, presenting for appointment will be eligible to participate

Be between 18 and 65 years old

Must not have

Patients with a personal history of CRC are not eligible to participate

Patients who do not speak Spanish or English or have severely impaired hearing or speech or do not give informed consent will also be excluded from participation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three years

Awards & highlights

No Placebo-Only Group

Summary

This trial is looking at how to best screen for colon cancer in a group of under- and uninsured patients in Dallas, in order to find the most effective and efficient way to do this.

Who is the study for?

This trial is for men and women aged 25-64 who are visiting the clinic. Those aged 25-49 must have a family history of colorectal cancer or their own history of bowel disease or polyps. All racial and ethnic groups, as well as English and Spanish speakers, can join. People with personal colorectal cancer history, severe hearing/speech impairments, or without informed consent cannot participate.

What is being tested?

The PROSPR project aims to find the best ways to screen for colon cancer in a diverse group using safety-net clinics. It will test tools like step completion assessments and computerized risk stratification algorithms to personalize screening methods based on individual risks.

What are the potential side effects?

Since this study focuses on screening optimization rather than medication or invasive procedures, traditional side effects are not applicable here. However, there may be indirect consequences related to privacy concerns or anxiety from personalized risk assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 25 and 64 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have never had colorectal cancer.

Select...

I speak English or Spanish and can hear, speak, and have given my consent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three years

This trial's timeline: 3 weeks for screening, Varies for treatment, and three years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of patients achieving appropriate screening regimen.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ScreeningExperimental Treatment3 Interventions

Employ innovative methods for assessing personalized guideline-based screening in the clinic setting to evaluate guideline-based, over- and under-screening. Interventions include Computerized Risk Stratification Tool, Algorithmic Risk Stratification Tool, and Step completion assessment.

0 / 3Eligibility criteria met